Document is current
Any future updates will be listed below
-
Authors
Viscusi, Eugene R. https://orcid.org/0000-0003-0260-4396
Epelde, Francisco https://orcid.org/0000-0001-5547-4025
Roca Ruiz, Luis Javier https://orcid.org/0000-0002-9334-101X
Trillo-Calvo, Eva https://orcid.org/0000-0003-0816-3579
-
Funding
Funding for this research was provided by:
Esteve Pharmaceuticals
- License Information
-
More Information
Article History
Received: 7 July 2024
Accepted: 12 August 2024
First Online: 21 September 2024
Declarations
:
: Eugene R. Viscusi reports consulting fees from ESTEVE Pharmaceuticals, Heron Therapeutics, Merck, Orion Pharma, Salix Pharmaceuticals, and Vertex Pharmaceuticals. Francisco Epelde, Luis Javier Roca Ruiz, and Eva Trillo-Calvo declare that they have no competing interests.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
